Tenet Healthcare (NYSE:THC) Stock Rating Upgraded by Wall Street Zen

Tenet Healthcare (NYSE:THC) was upgraded by equities researchers at Wall Street Zen from a “hold” rating to a “buy” rating in a report released on Sunday.

Several other equities research analysts also recently issued reports on THC. TD Cowen lowered their price target on Tenet Healthcare from $242.00 to $233.00 and set a “buy” rating for the company in a report on Monday, June 22nd. Royal Bank Of Canada lowered their target price on Tenet Healthcare from $277.00 to $236.00 and set an “outperform” rating for the company in a research note on Friday, May 1st. Morgan Stanley set a $254.00 target price on shares of Tenet Healthcare in a report on Friday, May 1st. Robert W. Baird reduced their price target on shares of Tenet Healthcare from $245.00 to $210.00 and set a “neutral” rating for the company in a report on Tuesday, May 5th. Finally, Barclays raised their price objective on shares of Tenet Healthcare from $240.00 to $271.00 and gave the stock an “overweight” rating in a report on Friday. Seventeen analysts have rated the stock with a Buy rating and four have assigned a Hold rating to the stock. Based on data from MarketBeat.com, Tenet Healthcare has a consensus rating of “Moderate Buy” and a consensus target price of $246.47.

Tenet Healthcare Trading Up 17.1%

NYSE THC opened at $233.10 on Friday. The company has a current ratio of 1.36, a quick ratio of 1.30 and a debt-to-equity ratio of 1.96. Tenet Healthcare has a 12 month low of $146.60 and a 12 month high of $247.21. The company has a market capitalization of $20.08 billion, a PE ratio of 8.99, a P/E/G ratio of 1.93 and a beta of 1.27. The stock has a 50-day simple moving average of $185.16 and a 200 day simple moving average of $197.62.

Tenet Healthcare (NYSE:THC) last announced its quarterly earnings results on Friday, July 24th. The company reported $6.12 EPS for the quarter, beating analysts’ consensus estimates of $4.26 by $1.86. Tenet Healthcare had a return on equity of 27.17% and a net margin of 10.27%.The company had revenue of $6.04 billion during the quarter, compared to analysts’ expectations of $5.43 billion. During the same period in the prior year, the business posted $4.02 EPS. Tenet Healthcare’s revenue was up 6.8% on a year-over-year basis. Research analysts forecast that Tenet Healthcare will post 21 EPS for the current year.

Insider Activity at Tenet Healthcare

In other news, Director J Robert Kerrey sold 5,638 shares of the firm’s stock in a transaction that occurred on Thursday, May 28th. The stock was sold at an average price of $174.52, for a total value of $983,943.76. Following the completion of the sale, the director directly owned 16,804 shares of the company’s stock, valued at $2,932,634.08. This trade represents a 25.12% decrease in their ownership of the stock. The transaction was disclosed in a filing with the SEC, which is available at this link. Also, Director Nadja West sold 3,000 shares of the stock in a transaction on Wednesday, May 27th. The shares were sold at an average price of $177.35, for a total value of $532,050.00. Following the completion of the sale, the director owned 24,805 shares in the company, valued at approximately $4,399,166.75. This trade represents a 10.79% decrease in their position. The disclosure for this sale is available in the SEC filing. Corporate insiders own 0.97% of the company’s stock.

Institutional Trading of Tenet Healthcare

A number of institutional investors have recently bought and sold shares of THC. NewEdge Advisors LLC increased its holdings in Tenet Healthcare by 6.1% in the 1st quarter. NewEdge Advisors LLC now owns 2,890 shares of the company’s stock valued at $389,000 after buying an additional 166 shares during the period. Jones Financial Companies Lllp raised its position in Tenet Healthcare by 299.1% during the first quarter. Jones Financial Companies Lllp now owns 1,700 shares of the company’s stock valued at $229,000 after purchasing an additional 1,274 shares in the last quarter. Sivia Capital Partners LLC bought a new stake in Tenet Healthcare during the second quarter worth $290,000. Quantbot Technologies LP bought a new position in shares of Tenet Healthcare in the 2nd quarter valued at $65,000. Finally, Amundi raised its holdings in shares of Tenet Healthcare by 4,207.8% during the 2nd quarter. Amundi now owns 27,010 shares of the company’s stock worth $4,652,000 after buying an additional 26,383 shares in the last quarter. Institutional investors own 95.44% of the company’s stock.

Tenet Healthcare News Summary

Here are the key news stories impacting Tenet Healthcare this week:

• Positive Sentiment: Tenet beat Q2 expectations by a wide margin, reporting $6.12 EPS versus estimates around $4.26, while revenue of $6.04 billion also came in above forecasts. The company cited strong same-store revenue growth and effective expense management. Tenet Reports Strong Second Quarter 2026 Results; Raises 2026 Financial Outlook
• Positive Sentiment: Management raised FY 2026 EPS guidance to $20.30-$21.69, well above prior Street expectations, signaling that the earnings beat may not be a one-quarter event. Tenet Reports Strong Second Quarter 2026 Results; Raises 2026 Financial Outlook
• Positive Sentiment: Investor enthusiasm was further supported by commentary highlighting hospital growth, expense control, and M&A momentum, with multiple reports describing the quarter as a “blockbuster” and noting the stock’s strong response. Tenet’s Blockbuster Quarter Sends Stock Flying, 2026 Outlook Gets Major Upgrade
• Neutral Sentiment: Tenet’s earnings call transcript and presentation may provide more detail on the quarter and outlook, but the main stock driver today appears to be the earnings beat and guidance increase rather than any new strategic surprise. Tenet Healthcare Corporation (THC) Q2 2026 Earnings Call Transcript
• Neutral Sentiment: Media coverage also noted broader strength in hospital stocks, which may be adding to the move in Tenet Healthcare (THC). Why Tenet Healthcare Stock Is Soaring Today

Tenet Healthcare Company Profile

Tenet Healthcare Corporation (NYSE: THC) is a diversified American healthcare services company that owns and operates acute care hospitals and a broad range of outpatient facilities. Its portfolio includes general acute-care hospitals, specialty hospitals, ambulatory surgery centers, urgent care and diagnostic imaging centers, and other ancillary service locations. Tenet’s operations are oriented around delivering inpatient and outpatient clinical care across multiple medical specialties, with an emphasis on surgical services, emergency care, and advanced diagnostics.

In addition to facility-based care, Tenet provides integrated services designed to support clinical operations and improve patient access and care coordination.